U.S. markets closed
  • S&P Futures

    3,829.00
    +19.75 (+0.52%)
     
  • Dow Futures

    31,024.00
    +112.00 (+0.36%)
     
  • Nasdaq Futures

    12,995.00
    +84.00 (+0.65%)
     
  • Russell 2000 Futures

    2,222.80
    +23.60 (+1.07%)
     
  • Crude Oil

    62.34
    +0.84 (+1.37%)
     
  • Gold

    1,736.20
    +7.40 (+0.43%)
     
  • Silver

    26.78
    +0.34 (+1.30%)
     
  • EUR/USD

    1.2093
    -0.0093 (-0.76%)
     
  • 10-Yr Bond

    1.4600
    -0.0580 (-3.82%)
     
  • Vix

    27.95
    -0.94 (-3.25%)
     
  • GBP/USD

    1.3968
    -0.0045 (-0.32%)
     
  • USD/JPY

    106.5010
    +0.2710 (+0.26%)
     
  • BTC-USD

    45,576.92
    -977.76 (-2.10%)
     
  • CMC Crypto 200

    912.88
    -20.25 (-2.17%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    28,966.01
    -1,202.29 (-3.99%)
     

PTC Therapeutics to Present at the Jefferies Virtual Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

SOUTH PLAINFIELD, N.J., May 26, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the Jefferies Virtual Healthcare Conference on Tuesday, June 2nd at 1:00 p.m. ET.

The presentation will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

FOR MORE INFORMATION PLEASE CONTACT:


Media:

Investors:

Jane Baj

Alex Kane

+1 (908) 912-9167

+1 (908) 912-9643

jbaj@ptcbio.com

akane@ptcbio.com

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-at-the-jefferies-virtual-healthcare-conference-301063111.html

SOURCE PTC Therapeutics, Inc.